Amyris | AMRS

Amyris traded at $1.41 this Friday March 24th, decreasing $0.04 or 2.76 percent since the previous trading session. Looking back, over the last four weeks, Amyris lost 11.02 percent. Over the last 12 months, its price fell by 67.59 percent. Looking ahead, we forecast Amyris to be priced at 1.23 by the end of this quarter and at 1.12 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
1.35
Daily Change
-6.90%
Yearly
-67.86%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Advanced Emissions 1.94 -0.03 -1.49% -68.55%
Albemarle 214.98 -0.66 -0.31% -1.20%
Amyris 1.35 -0.10 -6.90% -67.86%
BASF 45.80 -0.58 -1.24% -11.60%
Braskem 17.91 1.27 7.63% -60.65%
Capstone Green Energy Corp 1.45 0.02 1.40% -66.04%
Croda International 6,404.00 -60.00 -0.93% -13.86%
Chevron 155.86 1.34 0.87% -7.94%
DSM 109.20 -4.15 -3.66% -31.00%
Enphase Energy 192.86 -11.80 -5.77% -0.49%
FutureFuel 7.19 0.07 0.98% -27.08%
Flotek Industries 0.69 -0.02 -2.73% -50.67%
Givaudan 2,953.00 4.00 0.14% -22.17%
HollyFrontier 47.56 -0.66 -1.37% 21.05%
Marathon Petroleum 124.35 -1.80 -1.43% 51.22%
Plug Power 11.04 -0.45 -3.94% -60.51%
Solvay 98.68 -1.08 -1.08% 7.35%
Exxon Mobil 103.38 -0.03 -0.03% 21.34%

Indexes Price Day Year
USND 11738 -49.87 -0.42% -17.16%
US2000 1720 -0.57 -0.03% -17.24%

Amyris
Amyris, Inc. is a synthetic biotechnology company. The Company applies its Lab-to-Market biotechnology platform to engineer, manufacture and market high performance, natural and sustainably sourced products using its computational tools, strain construction tools, screening and analytics tools, and advanced lab automation and data integration. The Company's biotechnology platform enables users to rapidly engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into high-value ingredients that it manufactures at industrial scale. Through the combination of its biotechnology platform and industrial fermentation process, the Company has developed, produced, and commercialized many distinct molecules. The Company is focused on three market areas, Health & Wellness, Clean Beauty and Flavor & Fragrance.